Montagu Acquisitions: How Montagu Built Its Business Through M&A

Montagu acquisitions show how a European mid-market private equity firm used M&A to build exposure to businesses that support critical economic functions. From 1995 to 2025, Montagu completed 33 acquisitions with a total disclosed deal value of about $16.2 billion and an average disclosed deal size of roughly $492.2 million.

The company’s acquisition activity has focused mainly on manufacturing, healthcare, biotechnology, information technology, and business intelligence. Manufacturing accounts for 10 deals, health care and biotechnology each account for 4, information technology accounts for 3, and business intelligence accounts for 2.

That mix reflects Montagu’s positioning as a mid-market private equity firm committed to finding and growing businesses that make the world work. Its acquisition record includes medical device components, fund administration software, maritime intelligence, education software, surgical implants, defence intelligence, packaging imaging technologies, healthcare products, broadcast infrastructure, waste management, hosting, consumer electronics, and plastic packaging.

The most recent listed acquisition is Multifonds, acquired from Temenos in 2025 for about $400 million. Multifonds is a global fund administration software business serving fund administrators, asset managers, insurers, pension funds, and other financial institutions across multiple jurisdictions. Temenos announced the sale in February 2025, and the transaction was later reported as completed in June 2025.

What Is Montagu?

Montagu is a mid-market private equity firm focused on finding and growing businesses that perform important roles in their industries. Its acquisition history shows a preference for companies with specialist expertise, recurring demand, technical capability, regulated-market exposure, or mission-critical services.

Unlike a corporate acquirer buying companies to merge into one operating group, Montagu invests as a private equity owner. Its goal is to acquire or back businesses, support management teams, improve operations, strengthen market position, and eventually create value through growth and exit opportunities.

The firm’s acquisition record shows a strong interest in companies that serve essential or specialized needs. These include fund accounting software, medical device components, maritime intelligence, defence data, healthcare products, broadcast infrastructure, education software, ophthalmic surgery instruments, drug delivery systems, waste management, and hosting.

This gives Montagu’s acquisition strategy a clear theme: back businesses that may not always be consumer-facing but are deeply embedded in the systems that keep industries operating.

Why Montagu Acquisitions Matter

Montagu acquisitions matter because they show how private equity can target the “infrastructure behind the infrastructure.” Many of Montagu’s targets are not flashy consumer brands. Instead, they provide tools, services, components, data, systems, and platforms that other organizations rely on.

Multifonds is a good example. The company provides fund administration software used for critical back- and middle-office functions such as fund accounting, transfer agency, net asset value calculations, investor lifecycle support, KYC, and AML processes. Montagu said Multifonds is used to administer more than $10 trillion of assets, making it a significant platform in the global financial system.

The same logic applies to other acquisitions. Lloyd’s List Intelligence provides insight into global maritime trade. Janes provides open-source defence intelligence. Nemera develops drug delivery solutions. Johnson Matthey’s medical device components business supplies manufacturers of medical devices. Emitel operates broadcast infrastructure. Biffa and Cory Environmental operate in waste management.

These businesses are attractive because customers often depend on them. They may serve regulated markets, require technical expertise, or provide information and systems that are difficult to replace.

Full List of Montagu Acquisitions

The table below summarizes 20 notable Montagu acquisitions from the available acquisition record.

Montagu Acquisitions Timeline

2003: Packaging Manufacturing With LINPAC Group

Montagu’s available acquisition record includes LINPAC Group in 2003. LINPAC manufactured and marketed plastic packaging.

This acquisition fit Montagu’s manufacturing focus. Packaging is often a practical, industrially important sector because it supports food, consumer goods, logistics, retail, and supply chains.

LINPAC also reflected a recurring feature of Montagu acquisitions: the target had a defined industrial role and served real operating needs.

2004: Consumer Electronics Retail

In 2004, Montagu acquired Maplin Electronics for $435.0 million. Maplin was an online retailer of consumer electronics.

This acquisition gave Montagu exposure to e-commerce, consumer electronics, and smart-home-related retail. While later Montagu deals became more concentrated in healthcare, data, and infrastructure, Maplin shows that the firm also invested in consumer-facing platforms when they had clear market relevance.

2005: Healthcare Products and Waste Management

In 2005, Montagu acquired Cory Environmental and BSN Medical. Cory Environmental operated in waste management, while BSN Medical was a global healthcare company focused on compression therapy and related medical areas.

These deals show two major Montagu themes: healthcare and essential services. Waste management is a basic infrastructure service. Healthcare products serve clinical and patient needs. Both sectors can offer recurring demand and operational importance.

BSN Medical was also one of Montagu’s largest listed acquisitions, valued at $1.2 billion.

2006: Clinical Diagnostics With Sebia

In 2006, Montagu acquired Sebia for $508.0 million. Sebia provides clinical protein electrophoresis equipment and reagents.

This acquisition strengthened Montagu’s exposure to healthcare diagnostics and biotechnology. Diagnostic equipment and reagents can be attractive because they are used repeatedly in clinical workflows and require trust, regulatory compliance, and technical reliability.

2007: Consumer Beauty With GHD

In 2007, Montagu acquired GHD for $160.0 million. GHD manufactures hair-care styling products and accessories from Britain.

This deal added consumer brand exposure. GHD was different from Montagu’s healthcare, data, and industrial deals, but it still offered a clear investment case: a recognizable brand in beauty and consumer electronics with potential for growth.

2008: Waste Management Scale With Biffa

In 2008, Montagu acquired Biffa for $3.4 billion. Biffa is an integrated waste management company providing collection, landfill, recycling, and special waste services.

This was the largest listed Montagu acquisition in the available record. It showed the firm’s willingness to back large essential services platforms.

Waste management can be attractive to private equity because customers need reliable service, regulation creates barriers, and environmental requirements can support long-term demand. At the same time, it is operationally complex and capital-intensive.

2010: Hosting and Cloud Infrastructure

In 2010, Montagu acquired Host Europe Group for $347.0 million. Host Europe Group provided domain registration, mass hosting, customized managed hosting, and cloud hosting.

This acquisition gave Montagu exposure to digital infrastructure. Hosting and cloud services are critical for businesses that need websites, applications, and managed online operations.

The deal also showed Montagu investing in the digital backbone of business activity rather than only traditional industrial assets.

2011: Broadcast Infrastructure in Poland

In 2011, Montagu acquired Emitel for $609.0 million. Emitel was the leading terrestrial radio and TV broadcast infrastructure operator in Poland.

Broadcast infrastructure fits Montagu’s “essential systems” theme. While audiences may see television and radio content, the underlying transmission infrastructure is what makes distribution possible.

The acquisition added infrastructure exposure in a regulated and technically specialized market.

2012: Food and Beverage With St Hubert

In 2012, Montagu acquired St Hubert SAS for $544.0 million. St Hubert produces and markets spreads in France.

This deal gave Montagu exposure to food and beverage, a sector where brand, distribution, repeat purchase behavior, and retail relationships can drive value.

The acquisition also showed that Montagu’s portfolio was not limited to healthcare and infrastructure. It could also include consumer staples when the target had a strong market position.

2014: Drug Delivery and Ophthalmic Surgery

In 2014, Montagu acquired Nemera and Dutch Ophthalmic Research Center. Nemera was acquired for $805.0 million and is a global leader in drug delivery solutions. Dutch Ophthalmic Research Center provides instruments for ophthalmic surgery.

This was a major healthcare year for Montagu. Nemera gave the firm exposure to drug delivery devices, an important area where engineering, manufacturing, regulation, and patient use all intersect. Dutch Ophthalmic Research Center added surgical instruments for eye care.

Together, these deals show Montagu moving deeper into specialized healthcare technology and manufacturing.

2018: Software and Hardware With Servelec

In 2018, Montagu acquired Servelec Group for $309.0 million. Servelec was a UK-based technology group with significant intellectual property, providing software, hardware, and services.

This acquisition added technology and information systems exposure. It fit Montagu’s broader strategy of backing businesses with proprietary products and recurring customer relevance.

2019: Defence Intelligence and Packaging Imaging

In 2019, Montagu acquired Janes and Miraclon. Janes is a global open-source defence intelligence provider. Miraclon provides imaging technologies for the graphics customization of printed packaging materials.

Janes strengthened Montagu’s business intelligence theme. Defence intelligence is a specialist market where accuracy, trust, and data integration matter.

Miraclon added manufacturing and imaging technology linked to packaging. This continued Montagu’s investment in technically specialized industrial businesses.

2020: Medical Implants and Education Software

In 2020, Montagu acquired RTI Surgical’s OEM business and Capita’s Education Software Solutions.

RTI Surgical’s OEM business designs, develops, manufactures, and distributes biologic, metal, and synthetic implants. The acquisition strengthened Montagu’s healthcare manufacturing exposure.

Capita’s Education Software Solutions provided management information systems for education customers. This deal expanded Montagu’s software exposure in an essential public-service-adjacent market.

2022: Maritime Intelligence

In 2022, Montagu acquired Lloyd’s List Intelligence for $469.0 million. Lloyd’s List Intelligence provides tailored insight into global maritime trade.

This acquisition fit the firm’s business intelligence strategy. Maritime trade is central to global commerce, and customers need reliable information on vessels, logistics, shipping risk, and trade flows.

2024: Medical Device Components

In 2024, Montagu acquired Johnson Matthey’s medical device components business for $704.0 million. The business manufactures components for medical device manufacturers.

This acquisition strengthened Montagu’s healthcare manufacturing platform. Medical device components require quality systems, technical expertise, regulatory discipline, and customer trust.

2025: Fund Administration Software With Multifonds

In 2025, Montagu agreed to acquire Multifonds from Temenos for about $400 million. Temenos described Multifonds as a global fund administration software business serving all asset classes across multiple jurisdictions. The platform serves fund administrators, asset managers, insurers, and pension funds.

Montagu said Multifonds is used to administer more than $10 trillion of assets and performs critical back- and middle-office functions, including net asset value calculations, investment management support, KYC, AML, and investor lifecycle services.

The acquisition is strategically important because it adds a mission-critical financial technology platform to Montagu’s portfolio. It also fits the firm’s preference for specialist businesses embedded in complex, regulated workflows.

Biggest Montagu Acquisitions by Deal Value

Montagu’s largest disclosed acquisitions show the firm’s ability to pursue meaningful mid-market and upper mid-market platform deals across essential services, healthcare, manufacturing, infrastructure, and software.

The ranking shows Montagu’s broad investment mandate. The largest deals span waste management, packaging, healthcare products, drug delivery, medical components, broadcast infrastructure, food, education software, diagnostics, and surgical implants.

Most Common Acquisition Categories

Montagu acquisitions are concentrated in manufacturing, healthcare, biotechnology, information technology, and business intelligence.

This category mix reflects a strategy focused on businesses with technical capability, recurring demand, customer reliance, and operational importance.

Strategic Lessons From Montagu Acquisitions

Mission-Critical Businesses Attract Private Equity

Montagu acquisitions show the appeal of companies that customers rely on for essential functions. Multifonds supports fund administration. Lloyd’s List Intelligence supports maritime trade insight. Janes supports defence intelligence. Nemera supports drug delivery. Biffa supports waste management.

These businesses may operate in different sectors, but the strategic pattern is similar: they are difficult to replace and important to customer operations.

Manufacturing Still Matters

Manufacturing is the most common acquisition category in Montagu’s record. This includes packaging, medical device components, imaging technologies, drug delivery devices, diagnostics, and healthcare products.

The lesson is that private equity value is not limited to software. Specialist manufacturing can be attractive when it serves regulated or technical markets.

Data and Software Are Becoming More Important

Recent acquisitions such as Multifonds, Lloyd’s List Intelligence, Janes, Servelec, Host Europe Group, and Education Software Solutions show Montagu’s increasing exposure to data and software.

These businesses can offer recurring revenue, customer stickiness, and operational leverage when managed well.

How Montagu Acquisitions Fit Its Business Model

Montagu’s business model is based on investing in mid-market companies that have strong positions in essential sectors. Its acquisitions fit this model because many targets serve customers in regulated, technical, or operationally important markets.

A fund administrator using Multifonds may rely on the software for daily operations. A medical device company may depend on specialized components. A shipper or insurer may depend on maritime intelligence. A healthcare provider may rely on diagnostics or surgical instruments. A city or industrial customer may depend on waste management services.

These are not optional luxuries. They are services and products that support core functions.

That gives Montagu a clear private equity logic: acquire businesses with strong customer dependency, improve their operations, support growth, and create value over time.

Financial and Ownership Context

Montagu completed 33 acquisitions from 1995 to 2025. Total disclosed deal value was about $16.2 billion, with an average disclosed deal size of approximately $492.2 million.

The largest listed acquisition was Biffa at $3.4 billion. Other major deals included LINPAC Group, BSN Medical, Nemera, Johnson Matthey’s medical device components business, Emitel, St Hubert, Capita’s Education Software Solutions, Sebia, and RTI Surgical’s OEM business.

The Multifonds transaction was valued at about $400 million, including an earnout, according to Temenos. The Multifonds management team was also set to invest alongside Montagu, which is common in private equity transactions where management continuity matters.

This financial pattern shows Montagu investing in meaningful mid-market companies rather than very small venture-style targets. Its average deal size suggests a strategy built around established businesses with scale and market relevance.

Competitive Impact of Montagu Acquisitions

Montagu acquisitions have strengthened the firm’s position as a specialist mid-market investor. The firm has built a record across healthcare, manufacturing, data, infrastructure, environmental services, software, and business intelligence.

This breadth can help Montagu compete for carve-outs, founder-led companies, and specialist assets. The Multifonds deal is a strong example of a carve-out from a corporate parent. Temenos said the sale simplified its own product portfolio, while Montagu positioned Multifonds as a standalone company with management investment.

Montagu’s experience with specialized businesses can also appeal to sellers who want an investor that understands complex markets. A medical device components business, fund administration software platform, defence data provider, or maritime intelligence company requires more than generic financial engineering.

However, competition for such assets can be intense. Other private equity firms, strategic buyers, infrastructure funds, and software investors may also pursue businesses with recurring demand and mission-critical characteristics.

Advantages of the Acquisition Strategy

Exposure to Essential Services

Montagu has acquired businesses in waste management, healthcare, fund administration software, maritime intelligence, defence intelligence, and broadcast infrastructure.

Strong Technical and Regulated-Market Focus

Many targets operate in markets where quality, compliance, and specialist knowledge matter.

Diversified Portfolio Themes

The acquisition record spans manufacturing, healthcare, software, business intelligence, infrastructure, food, consumer products, and environmental services.

Customer Stickiness

Businesses such as Multifonds, Janes, Lloyd’s List Intelligence, Nemera, and Education Software Solutions can be embedded in customer workflows.

Carve-Out Opportunity

Several deals involve assets from larger corporate groups, which can create opportunities to build standalone businesses with focused management.

Disadvantages of the Acquisition Strategy

Integration and Carve-Out Complexity

Carve-outs can be difficult. Systems, people, contracts, technology, branding, and operations must be separated carefully from the seller.

Sector Complexity

Montagu invests across diverse sectors. Healthcare manufacturing, financial software, maritime data, waste management, and consumer products require different expertise.

Regulatory Exposure

Healthcare, fund administration, defence intelligence, waste management, and environmental services can all face regulatory or compliance obligations.

Cyclical and Operational Risk

Manufacturing, packaging, infrastructure, food, and waste services can face cost pressure, supply chain challenges, labor issues, and economic cycles.

Valuation Risk

Mission-critical businesses can command high prices. Paying too much can reduce returns even when the business quality is strong.

Case Studies of Major Montagu Acquisitions

Biffa

Biffa was Montagu’s largest listed acquisition, valued at $3.4 billion. The company provides integrated waste management services, including collection, landfill, recycling, and special waste services.

This deal fits Montagu’s essential services theme. Waste management is a necessary function for households, businesses, and public systems. It is also highly operational and regulated.

The acquisition shows Montagu’s willingness to back large infrastructure-like service platforms.

Multifonds

Multifonds was acquired from Temenos for about $400 million. It provides fund administration software across multiple jurisdictions and asset classes. Montagu said the platform is used to administer more than $10 trillion of assets and performs critical back- and middle-office fund services.

This acquisition fits Montagu’s strategy of investing in mission-critical software. Fund administration is complex, regulated, and operationally sensitive. Software that supports NAV calculations, KYC, AML, and investor lifecycle processes can become deeply embedded in customer operations.

Nemera

Nemera was acquired for $805.0 million in 2014. It is a leader in the design, development, and manufacturing of drug delivery solutions.

The acquisition strengthened Montagu’s healthcare manufacturing exposure. Drug delivery devices sit at the intersection of engineering, patient experience, pharma partnerships, and regulatory standards.

Johnson Matthey’s Medical Device Components Business

Montagu acquired Johnson Matthey’s medical device components business for $704.0 million in 2024. The business manufactures components for medical device manufacturers.

This acquisition added specialized healthcare manufacturing capability. Components used in medical devices must meet strict quality and performance standards, making the business technically and commercially important.

Janes

Janes was acquired for $470.0 million in 2019. The company provides open-source defence intelligence and connected insights.

This acquisition illustrates Montagu’s interest in business intelligence. Defence intelligence customers rely on accurate, structured, and timely data. Such businesses can be attractive because trust and expertise are difficult to replicate.

Common Mistakes When Analyzing Montagu Acquisitions

Treating Montagu Like a Corporate Acquirer

Montagu is a private equity firm, not an operating company buying businesses to merge into one group. Its acquisitions should be analyzed through investment strategy, value creation, management support, and exit potential.

Looking Only at the Largest Deal

Biffa was the largest listed acquisition, but Montagu’s strategy is broader. Healthcare, software, data, fund administration, and manufacturing are all central themes.

Ignoring Carve-Out Dynamics

Several acquisitions involve corporate carve-outs. These require careful separation and standalone business building.

Overlooking Mission-Critical Software

Multifonds, Education Software Solutions, Servelec, Host Europe Group, Janes, and Lloyd’s List Intelligence show that software and data are important to Montagu’s strategy.

Assuming Manufacturing Is Low-Tech

Montagu’s manufacturing deals often involve medical devices, packaging technologies, diagnostics, drug delivery, and specialized components. These are not generic manufacturing assets.

Lessons for Business Owners and Investors

Montagu’s acquisition history offers several lessons.

First, essential businesses can be highly attractive even when they are not consumer-facing. Fund software, medical components, defence intelligence, and maritime data all serve critical functions.

Second, mid-market private equity can create value through focus. Many acquired businesses can benefit from becoming standalone platforms with dedicated management and investment.

Third, technical manufacturing remains valuable. Healthcare components, diagnostics, ophthalmic instruments, and drug delivery systems show how engineering expertise can create defensible positions.

Fourth, data businesses can be powerful when customers depend on accuracy and continuity. Janes and Lloyd’s List Intelligence are strong examples.

Finally, private equity success depends on execution after acquisition. Carve-outs, platform growth, product investment, and management alignment must all be handled well.

Key Takeaways

• Montagu completed 33 acquisitions from 1995 to 2025.
• Total disclosed deal value was about $16.2 billion.
• The average disclosed acquisition size was approximately $492.2 million.
• Manufacturing was the most common category, with 10 deals.
• Health care and biotechnology each accounted for 4 acquisitions.
• Information technology accounted for 3 acquisitions.
• Business intelligence accounted for 2 acquisitions.
• The largest listed acquisition was Biffa at $3.4 billion.
• The most recent listed acquisition was Multifonds, acquired from Temenos for about $400 million.
• Montagu’s strategy focuses on essential businesses in healthcare, manufacturing, data, software, infrastructure, and specialist services.
• Recent acquisitions show growing interest in mission-critical financial software, medical device components, and business intelligence.
• Key risks include carve-out complexity, regulatory exposure, sector diversity, operational risk, and valuation discipline.

Frequently Asked Questions

What are Montagu acquisitions?

Montagu acquisitions are companies acquired or backed by Montagu as part of its private equity strategy focused on mid-market businesses in essential sectors.

How many acquisitions has Montagu made?

Montagu has made 33 acquisitions across the period from 1995 to 2025.

What is the total value of Montagu acquisitions?

The total disclosed value of Montagu acquisitions is about $16.2 billion.

What is Montagu’s average acquisition size?

Montagu’s average disclosed acquisition size is approximately $492.2 million.

What was Montagu’s most recent listed acquisition?

Montagu’s most recent listed acquisition is Multifonds, acquired from Temenos in a transaction valued at about $400 million.

What is Montagu’s biggest listed acquisition?

The biggest listed Montagu acquisition is Biffa, acquired in 2008 for $3.4 billion.

Which sectors does Montagu focus on?

Montagu acquisitions focus on manufacturing, healthcare, biotechnology, information technology, business intelligence, financial software, infrastructure, environmental services, and specialist business services.

Why did Montagu acquire Multifonds?

Montagu acquired Multifonds to back a mission-critical fund administration software platform used by asset managers, fund administrators, insurers, pension funds, and other financial institutions.

Why are healthcare acquisitions important to Montagu?

Healthcare acquisitions are important because Montagu has backed businesses in drug delivery, diagnostics, ophthalmic surgery instruments, medical device components, and medical implants.

What are the risks of Montagu’s acquisition strategy?

The main risks include carve-out execution, integration challenges, regulatory exposure, sector complexity, operational cost pressure, and valuation risk.

Conclusion

Montagu acquisitions show how a mid-market private equity firm can build value by backing businesses that perform essential functions across the economy. From 1995 to 2025, Montagu completed 33 acquisitions with total disclosed deal value of about $16.2 billion and an average disclosed deal size of roughly $492.2 million.

The acquisition record spans manufacturing, healthcare, biotechnology, software, business intelligence, financial technology, infrastructure, waste management, food, and consumer products. Major deals such as Biffa, LINPAC, BSN Medical, Nemera, Emitel, Sebia, RTI Surgical’s OEM business, Johnson Matthey’s medical device components business, Lloyd’s List Intelligence, Janes, and Multifonds show a consistent interest in businesses with critical roles in their markets.

For business owners and investors, Montagu acquisitions offer a clear lesson: the strongest private equity targets are not always the most visible companies. Often, they are the specialist platforms behind healthcare systems, financial operations, manufacturing supply chains, environmental services, infrastructure networks, and data-driven decision-making. Montagu’s M&A record shows a strategy built around those durable, practical, and mission-critical businesses.

Disclaimer: This article is for informational and educational purposes only. It is not investment advice, financial advice, or a recommendation to buy or sell any security. Always conduct your own research and consider speaking with a qualified financial adviser before making investment decisions.

Read Also; Mobeus Acquisitions: How Mobeus Built Its Business Through M&A